The mechanisms of cisplatin resistance, one of the major limitations of current chemotherapy, has only partially been described. We previously demonstrated that cisplatin-resistant ovarian cancer cells (C13), are characterized by reduced mitochondrial activity and higher glucose-dependency when compared to the cisplatin-sensitive counterpart (2008). In this work we further characterized the role of metabolic transformation in cisplatin resistance. By using transmitochondrial hybrids we show that metabolic reprogramming of cisplatin-resistant cell is not caused by inherent mtDNA mutations. We also found that C13 cells not only present an increased glucose-uptake and consumption, but also exhibit increased expression and enzymatic activity of the Pentose Phosphate pathway (PPP) enzyme Glucose-6-Phosphate Dehydrogenase (G6PDH). Moreover, we show that cisplatin-resistant cells are more sensitive to G6PDH inhibition. Even if the metabolomic fingerprint of ovarian cancer cells remains to be further elucidated, these findings indicate that PPP offers innovative potential targets to overcome cisplatin resistance.

Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death / Catanzaro, Daniela; Gaude, Edoardo; Orso, Genny; Giordano, Carla; Guzzo, Giulia; Rasola, Andrea; Ragazzi, Eugenio; Caparrotta, Laura; Frezza, Christian; Montopoli, Monica. - In: ONCOTARGET. - ISSN 1949-2553. - STAMPA. - 6:30(2015), pp. 30102-30114. [10.18632/oncotarget.4945]

Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death

GIORDANO, Carla;
2015

Abstract

The mechanisms of cisplatin resistance, one of the major limitations of current chemotherapy, has only partially been described. We previously demonstrated that cisplatin-resistant ovarian cancer cells (C13), are characterized by reduced mitochondrial activity and higher glucose-dependency when compared to the cisplatin-sensitive counterpart (2008). In this work we further characterized the role of metabolic transformation in cisplatin resistance. By using transmitochondrial hybrids we show that metabolic reprogramming of cisplatin-resistant cell is not caused by inherent mtDNA mutations. We also found that C13 cells not only present an increased glucose-uptake and consumption, but also exhibit increased expression and enzymatic activity of the Pentose Phosphate pathway (PPP) enzyme Glucose-6-Phosphate Dehydrogenase (G6PDH). Moreover, we show that cisplatin-resistant cells are more sensitive to G6PDH inhibition. Even if the metabolomic fingerprint of ovarian cancer cells remains to be further elucidated, these findings indicate that PPP offers innovative potential targets to overcome cisplatin resistance.
2015
PPP; cancer metabolism; cisplatin; drug resistance; transmitochondrial hybrids
01 Pubblicazione su rivista::01a Articolo in rivista
Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death / Catanzaro, Daniela; Gaude, Edoardo; Orso, Genny; Giordano, Carla; Guzzo, Giulia; Rasola, Andrea; Ragazzi, Eugenio; Caparrotta, Laura; Frezza, Christian; Montopoli, Monica. - In: ONCOTARGET. - ISSN 1949-2553. - STAMPA. - 6:30(2015), pp. 30102-30114. [10.18632/oncotarget.4945]
File allegati a questo prodotto
File Dimensione Formato  
Catanzaro_Glucose-6-phosphate_2015.pdf

accesso aperto

Note: https://www.oncotarget.com/article/4945/text/
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.71 MB
Formato Adobe PDF
1.71 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/789258
Citazioni
  • ???jsp.display-item.citation.pmc??? 46
  • Scopus 97
  • ???jsp.display-item.citation.isi??? 89
social impact